一般人群中饮酒与代谢综合征对严重肝病预测的交互作用
基于芬兰人群健康2000研究(2000-2001年)中6732名基线无肝病个体,随访至2013年分析肝脏相关入院、死亡和肝癌。随访期间84人发生严重肝脏事件。多变量模型中年龄、性别、饮酒、糖尿病、低密度脂蛋白胆固醇和胰岛素抵抗指数可预测肝脏事件;在酒精风险使用者中糖尿病是唯一显著预测因子。
要点
- 饮酒与代谢因素共同影响严重肝病风险,饮酒即使未超过非酒精性脂肪性肝病定义的限量仍具显著性。
- 酒精风险使用者(男性≥210 g/周,女性≥140 g/周)中糖尿病是唯一显著预测因子(HR 6.79)。
- 非风险饮酒者中年龄、饮酒、吸烟、腰围、低LDL胆固醇和HOMA-IR为独立预测因子。
核心结论
- 代谢综合征的多个组分独立影响严重肝病风险。
- 饮酒即使平均饮酒量在目前定义非酒精性脂肪性肝病的限量之内仍具显著性。
研究设计与样本
- 芬兰基于人群的健康2000研究(2000-2001年)全国代表性队列,纳入6732名基线无肝病个体,随访至2013年通过国家登记分析肝脏相关入院、死亡和肝癌。
- 采用向后逐步Cox回归分析基线饮酒和代谢因素。
主要发现
- 随访期间84人发生严重肝脏事件。
- 最终多变量模型中年龄HR 1.02(95%CI 1.004-1.04),女性HR 0.55(95%CI 0.34-0.91),饮酒HR 1.002(95%CI 1.001-1.002),糖尿病HR 2.73(95%CI 1.55-4.81),LDL胆固醇HR 0.74(95%CI 0.58-0.93),HOMA-IR HR 1.01(95%CI 1.004-1.02)。
- 酒精风险使用者(男性≥210 g/周,女性≥140 g/周)中糖尿病HR 6.79(95%CI 3.18-14.5)是唯一显著预测因子。
- 非风险饮酒者中年龄、饮酒、吸烟、腰围、低LDL胆固醇和HOMA-IR为显著独立预测因子。
- 总胆固醇与LDL胆固醇比值及腰围与体质指数比值作为额外独立预测因子出现。
关键数值与推荐
- 酒精风险使用定义为男性≥210 g/周,女性≥140 g/周。
- 糖尿病在酒精风险使用者中HR 6.79(95%CI 3.18-14.5)。
- 最终多变量模型中年龄HR 1.02(95%CI 1.004-1.04),女性HR 0.55(95%CI 0.34-0.91),饮酒HR 1.002(95%CI 1.001-1.002),糖尿病HR 2.73(95%CI 1.55-4.81),LDL胆固醇HR 0.74(95%CI 0.58-0.93),HOMA-IR HR 1.01(95%CI 1.004-1.02)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The metabolic syndrome and alcohol risk use are both associated with a high prevalence of hepatic steatosis, but only a minority develop liver failure or liver cancer. Few general population studies have analyzed metabolic predictors of such severe liver complications. We studied which metabolic factors best predict severe liver complications, stratified by alcohol consumption, in 6732 individuals without baseline liver disease who participated in the Finnish population-based Health 2000 Study (2000-2001), a nationally representative cohort. Follow-up data from national registers until 2013 were analyzed for liver-related admissions, mortality, and liver cancer. Baseline alcohol use and metabolic factors were analyzed by backward stepwise Cox regression analysis. Eighty-four subjects experienced a severe liver event during follow-up. In the final multivariate model, factors predictive of liver events were age (hazard ratio [HR], 1.02; 95% confidence interval [CI], 1.004-1.04), sex (women: HR, 0.55; 95% CI, 0.34-0.91), alcohol use (HR, 1.002; 95% CI, 1.001-1.002), diabetes (HR, 2.73; 95% CI, 1.55-4.81), low-density lipoprotein (LDL) cholesterol (HR, 0.74; 95% CI, 0.58-0.93), and homeostasis model assessment of insulin resistance (HOMA-IR) (HR, 1.01; 95% CI, 1.004-1.02). Among alcohol risk users (≥210 g/week for men, ≥ 140 g/week for women), diabetes (HR, 6.79; 95% CI, 3.18-14.5) was the only significant predictor. Among nonrisk drinkers, age, alcohol use, smoking, waist circumference, low LDL cholesterol and HOMA-IR were significant independent predictors. The total-to-LDL cholesterol ratio and waist circumference-to-body mass index ratio emerged as additional independent predictors. CONCLUSION: Multiple components of the metabolic syndrome independently affected the risk for severe liver disease. Alcohol was significant even when average alcohol consumption was within the limits currently defining nonalcoholic fatty liver disease. (Hepatology 2018;67:2141-2149).
引用
- Åberg F, Helenius-Hietala J, Puukka P, et al. Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population. Hepatology. 2018. PMID: 29164643. doi:10.1002/hep.29631
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。